This webcast has already been broadcasted.


Having the right system requirements means you don’t miss out on the webcast.

  1. Have you logged in using your Healthed account details?
    For computer – the blue Login button is at the top right hand corner of the screen. On smaller screens – the blue Login button is in the menu at the top left hand corner of the screen.
  2. Make sure your internet speed is 5mbps or higher.
    Go to to test your internet speed.
  3. Suitable browsers
    The webcast is best viewed on Google Chrome, Microsoft Edge, Firefox, Safari or Opera.
  4. System Requirement
    If you are watching the webcast at your practice or workplace or using an equipment provided by your employer, restrictions and blockers may be installed which prevent the webcast from streaming. To check your device, play the webcast preview by clicking on the Hot Topics Webcast window above. Also check that your speakers are connected.

If the webcast preview does not play, please use another device or watch the webcast at another location.

About Healthed webcasts

Healthed webcasts are a valuable educational platform, allowing viewers to gain up-to-date clinical knowledge through an easy, time-efficient format. Our free web-based seminars fill a huge unmet need amongst GPs outside of the major cities for quality, accessible education. Every Healthed webcast features at least three expert lectures and runs for at least 90 minutes. While the majority of our viewers are General Practitioners, our webcasts are also drawing growing interest from other HCPs, such as pharmacists and nurses. Registrants can watch stream the webcast on a computer, tablet or phone. Instructions on how to log in to the webcast will be emailed to registered delegates in the weeks before the event.

Healthed Webcast


May, 2021

6:30 pm - 9:00 pm | AEST

This webcast has already been broadcasted.

Topics & Speaker

LARCs – Myths and Misperceptions

Dr Terri Foran

Sexual Health Physician; Conjoint Senior Lecturer, School of Women’s and Children’s Health, UNSW

Dr Terri Foran is a Sexual Health Physician and has a special interest in contraception, menopause issues and the management of sexually transmitted infections. She was previously the Medical Director of Family Planning NSW and is now in clinical practice in Darlinghurst. She is also engaged in both clinical and research work at the Royal Hospital for Women in Sydney. Dr Foran holds the position of Lecturer at the University of New South Wales in the School of Women’s and Children’s Health. She coordinates Phase 2 of their undergraduate Women’s Health program as well as supervising a number of modules in the Masters of Reproductive Medicine and Masters of Women’s Health Medicine Programs offered by UNSW.
Topic Summary
LARCs are an important set of effective contraceptive options that Australian women should be more aware of. The ease of use and reliability should make them the first option for many women, yet they are not as widely used as they should be. Dr Foran will dispel some of the major myths and misperceptions that seem to impact LARC uptake, and provide practical advice on how to effectively communicate those with your patients.

Major Changes to the CPD Landscape Ahead - Statement from the AMA

Dr Omar Khorshid

President, Australian Medical Association (AMA)

Topic summary
Many of us have been hearing about changes to the CPD environment and that the two GP colleges will be losing their monopoly on CPD reporting. In the absence of a clear public statement from the GP colleges, the AMA has offered to make a short but definitive statement on this development. Dr Khorshid will explain why and how this is happening and how it will soon be possible for budget conscious GPs to self-manage their own CPD records, bypassing the need for college membership. The implications of this development are huge and GPs must be informed.

The AZ Vaccine - Clot Risks and Questions about Herd Immunity

Dr Michelle Ananda-Rajah

Infectious Diseases and General Medicine Physician; Founder, fungalAi; Co-Founder, Healthcare Workers Australia

Dr Michelle Ananda-Rajah is a physician in infectious diseases and general medicine at a major Melbourne hospital. She has research interests in artificial intelligence, health services research and the occupational safety of health care workers. Michelle is the founder of fungalAi, a platform technology that aims to facilitate faster surveillance and diagnosis of fungal infections in patients with blood cancers. In 2019, she was awarded a prestigious TRIP (Translating Research Into Practice) fellowship by the Medical Research Future Fund and appointed to JAMA Network Open as a statistical and methods reviewer. During the COVID-19 pandemic, Michelle has advocated for Australian healthcare workers and brought her critical thinking skills to the vaccine debate noting that she is not a vaccinologist. She is the co-founder of Healthcare Workers Australia, a grass-roots advocacy group supporting better work, health and safety standards for Australia's frontline.
Topic summary
The AZ vaccine is a key part of the Australian COVID prevention strategy. However, we must ask ourselves whether or not the risk of adverse effects, especially clots, is acceptable in the Australian context where COVID is more or less under control. This is a vital issue to grasp if we are to make reliable recommendations to our patients. Furthermore, we must take a close look at whether or not the efficacy of the AZ vaccine is high enough for us to achieve herd immunity. As the public becomes increasingly hesitant with regard to the AZ vaccine, the likelihood of us vaccinating enough of the population to achieve herd immunity diminishes rapidly. Michelle will walk us through the data, help us understand our role as GPs and look at what can be done to get our patients and the country back on track to long term protection against COVID19.

The New Herpes Zoster Vaccine

Prof Tony Cunningham AO

Infectious Diseases Physician; Director, Centre for Virus Research at The Westmead Institute for Medical Research

Professor Anthony Cunningham AO, FAHMS, MD, FRACP, FRCPA is an infectious diseases physician, clinical virologist and scientist. He is Director, Centre for Virus Research at The Westmead Institute for Medical Research (WIMR); Director, Australian Centre for HIV and Hepatitis Virology Research (ACH2); and Professor in the Faculty of Medicine and Health at the University of Sydney. Tony built up the NSW State Reference Laboratory in Virology in the mid-1980s before assuming directorship of WIMR in 1996. He was awarded Officer of the Order of Australia (AO) in 2010 for ‘service to medicine, particularly in the field of viral research and through the development of leadership of medical and biomedical research’, and in 2015, was elected as an inaugural Fellow of the Australian Academy of Health and Medical Sciences. Tony is the lead author of the ‘Vaccines for COVID-19’ paper, commissioned from the Australian Academy of Health and Medical Sciences and is a longstanding consultant for Seqirus, Merck and GSK on vaccines in the ageing and for shingles and herpes. Since stepping down from the WIMR director role, he has continued his research on a NHMRC Senior Investigator Grant and become immersed in COVID-19 research, amongst other advisory positions including the NSW COVID Vaccines Committee.
Topic summary
A new and important vaccine for Herpes Zoster prevention is now available in Australia. Prof Cunningham will describe in practical detail the evidence for its effectiveness, safety profile, indications and contraindications and what advantages it has over the currently available options.

Cardiac CTs - Patient Selection and What This Test Means

Prof David Playford

Cardiac Imaging Specialist; Consultant Cardiologist, GenesisCare; Professor of Cardiology, University of Notre Dame, Perth

Prof David Playford is a cardiac imaging specialist, having run a specialist echo laboratory, an echo core laboratory, and an advanced echo fellowship program. His clinical cardiology interests are general cardiology, cardiac risk assessment, breathlessness and pulmonary hypertension, heart failure and valvular heart disease. David is dual FRACP-trained in General Medicine and Cardiology, and is a Fellow of the Cardiac Society of Australia and New Zealand, the American College of Cardiology, the and the European Society of Cardiology. David is the Professor of Cardiology at the University of Notre Dame, where he was awarded the Vice Chancellor’s Award for Teaching Excellence, and coordinates the undergraduate cardiovascular teaching program. From a research perspective, his Doctor of Philosophy examined vascular function, lipid abnormalities and diabetes, and he subsequently undertook echocardiography training at Massachusetts General Hospital and Harvard Medical School, Boston USA. David is the Principal Investigator of the National Echo Database Australia (NEDA), the largest echo database in the world with links to mortality data. He also runs an artificial intelligence program focusing on automation of interpretation of echo and ECG data.
Topic summary
Why is coronary calcium score so important? David will explain why coronary CT is the single best test to identify the presence of coronary atherosclerosis, which is the actual pathology that causes AMI. Stress tests are useful but they don’t directly detect the pathology itself! Coronary calcium scores give the doctor the necessary information to treat and prevent atheroscloerosis-related cardiac events as well as improve symptoms. This lecture is essential to develop clear understanding of how best to use cardiac CT.

This webcast has already been broadcasted.